C ZENITH CHEM (00362) plans to issue new shares with a premium of approximately 13.64%, raising a maximum of approximately HK$57.9 million net.
China Tianhua Chemical Engineering (00362) announced that on September 20, 2024, the company entered into a placement agreement with the company's placement agent Richful Securities...
C ZENITH CHEM (00362) announced that on September 20, 2024, the company has mutually agreed with its placement agent Kingrich Securities Financial Limited to terminate the placement agreement for the issuance of new shares based on special authorization that was set to expire on August 22, 2024.
On the same day, the company entered into a new placement agreement with the placement agent, intending to issue up to 600 million shares at a placement price of HK$0.1 per share, to be subscribed by at least six underwriters, representing approximately 30.74% of the enlarged share capital. The placement price represents a premium of approximately 13.64% over the closing price of HK$0.088 per share on September 20, 2024.
Assuming all placement shares are fully subscribed, the company expects to raise net proceeds of approximately HK$57.9 million, with HK$50 million to be used to repay the group's debts and interest expenses, and HK$7.9 million to be used for general working capital purposes.
Related Articles

MIKO INTL (01247) released its annual performance report, with a shareholder's net loss of 59.014 million yuan, a year-on-year increase of 107.67%.

CEB BANK (06818) releases annual performance, net profit attributable to parent company is 38.826 billion yuan, a year-on-year decrease of 6.88%.

S.F. Holding (06936) significantly increases A-share repurchase funds to 3 billion to 6 billion yuan.
MIKO INTL (01247) released its annual performance report, with a shareholder's net loss of 59.014 million yuan, a year-on-year increase of 107.67%.

CEB BANK (06818) releases annual performance, net profit attributable to parent company is 38.826 billion yuan, a year-on-year decrease of 6.88%.

S.F. Holding (06936) significantly increases A-share repurchase funds to 3 billion to 6 billion yuan.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


